Armata Pharmaceuticals
ARMP • AMEX
Armata Pharmaceuticals is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Deborah L. Birx, with a market cap of $306.6M.
CEODeborah L. Birx
Next Earnings
Upcoming earnings announcement for Armata Pharmaceuticals
Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.41
Earnings History
Past 12 earnings reports for Armata Pharmaceuticals
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 25, 2026 | Q4 2025 | -$3.43Est: -$0.19 | -1705.3% | $1.1MEst: $1.0M | +4.7% | — |
| Nov 12, 2025 | Q3 2025 | -$0.74Est: -$0.42 | -76.2% | $1.2MEst: $1.4M | -16.0% |  10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.45Est: -$0.39 | -15.4% | $2.2MEst: $1.4M | +57.2% | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.20Est: -$0.38 | +47.4% | $491.0KEst: $1.4M | -64.4% | 10-Q |
| Mar 20, 2025 | Q4 2024 | -$0.23Est: -$0.35 | +34.3% | $1.2MEst: $1.6M | -20.8% | 10-K |
| Nov 13, 2024 | Q3 2024 | -$0.15Est: -$0.28 | +46.4% | $3.0MEst: $900.0K | +230.3% | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$0.25Est: -$0.44 | +43.2% | -Est: $1.1M | -100.0% | 10-Q |
| May 7, 2024 | Q1 2024 | -$0.69Est: -$0.31 | -122.6% | $966.0KEst: $1.1M | -12.2% | 10-Q |
| Mar 21, 2024 | Q4 2023 | -$0.55Est: -$0.35 | -57.1% | $1.5MEst: $860.0K | +77.7% | 10-K |
| Nov 14, 2023 | Q3 2023 | -$0.86Est: -$0.31 | -177.4% | $1.2MEst: $950.0K | +28.9% | — |
| Aug 14, 2023 | Q2 2023 | -$0.17Est: -$0.35 | +51.4% | $980.0KEst: $1.5M | -34.7% | 10-Q |
| May 11, 2023 | Q1 2023 | -$0.40Est: -$0.32 | -25.0% | $796.0KEst: $1.8M | -55.3% | 10-Q |